Filing Flows › Regen BioPharma (RGBP) › Q3 FY26 › vs Q2 FY26
Regen BioPharma (RGBP) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Regen BioPharma's revenue rose $0 (0%) from $59K in Q2 FY26 to $59K in Q3 FY26.
Regen BioPharma, Q3 FY26: revenue $59K (0% year over year), operating margin 41.5%, net loss $638K, operating cash flow −$24K. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $59K | $59K | $0 | 0% |
| Net loss | $638K | −$992K | $1.6M | — |
| Costs & expenses | $697K | $1.2M | −$508K | -42% |
| Operating costs | $35K | $213K | −$178K | -84% |
| Interest & other, net | $662K | −$1.1M | $1.8M | — |
| General & admin | $14K | $32K | −$18K | -57% |
| Other operating costs | $21K | $178K | −$158K | -88% |
| Operating cash sources | $638K | −$992K | $1.6M | — |
| Working capital & other | $614K | −$1.1M | $1.7M | — |
| Cash used in operations | $24K | $63K | −$39K | -62% |
| Net loss absorbed | $638K | −$992K | $1.6M | — |
Questions
How much did Regen BioPharma's revenue grow quarter over quarter in Q3 FY26?
Regen BioPharma's revenue rose $0 (0%) from $59K in Q2 FY26 to $59K in Q3 FY26.